Upcoming Workshops
Past Workshops
- Update on CAR T-Cell Therapies
- Taking Your Blood Cancer Adherence Treatment on Schedule
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- Highlights from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting – “Partnering With Patients: The Cornerstone of Cancer Care and Research”Part II of Highlights from the 2023 American Society of Clinical Oncology Meeting
- Diffuse Large B-Cell Lymphoma (DLBCL): New Treatment Approaches
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
- Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
- Update from the 2022 American Society of Hematology (ASH) Annual Meeting
- What’s New In Precision Medicine
- Update On Marginal Zone Lymphoma (MZL)
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
- Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
- Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
- Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
- Coping with the Stresses of Caregiving When Your Loved One Has Mantle Cell Lymphoma (MCL)Part II of Living with Mantle Cell Lymphoma (MCL)
- What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
- Transplantation as a Treatment Option for Blood Cancers
- Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)